Discovery and initial validation of α 1‐B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid‐resistant nephrotic syndrome
暂无分享,去创建一个
M. Mitsnefes | P. Devarajan | Q. Ma | M. Bennett | K. Czech | K. Greis | O. Kremen | N. Piyaphanee
[1] M. Bhasin,et al. Optimizing a Proteomics Platform for Urine Biomarker Discovery* , 2010, Molecular & Cellular Proteomics.
[2] S. Vyas,et al. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus , 2010, Pediatric Nephrology.
[3] E. Silverman,et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. , 2009, Arthritis and rheumatism.
[4] A. Papagianni,et al. Urinary levels of epidermal growth factor, interleukin‐6 and monocyte chemoattractant protein‐1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy , 2009, Nephrology.
[5] V. Thongboonkerd,et al. Are protease inhibitors required for gel-based proteomics of kidney and urine? , 2009, Journal of proteome research.
[6] M. Masellis,et al. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] Susan L Furth,et al. New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.
[8] A. Fisher,et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[9] G. Ross,et al. Using proteomics to identify preprocedural risk factors for contrast induced nephropathy , 2008, Proteomics. Clinical applications.
[10] R. Woroniecki,et al. Urinary Cytokines and Steroid Responsiveness in Idiopathic Nephrotic Syndrome of Childhood , 2007, American Journal of Nephrology.
[11] R. Craver,et al. Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[12] D. Stablein,et al. Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) * , 2007, Pediatric transplantation.
[13] M. Somers,et al. Focal and segmental glomerulosclerosis in children: a longitudinal assessment , 2007, Pediatric Nephrology.
[14] F. Scolari,et al. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. , 2007, Journal of the American Society of Nephrology : JASN.
[15] D. Gipson,et al. Therapeutic approach to FSGS in children , 2007, Pediatric Nephrology.
[16] F. Scolari,et al. Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome , 2006 .
[17] S. Hailpern,et al. Urinary Proteome of Steroid-Sensitive and Steroid-Resistant Idiopathic Nephrotic Syndrome of Childhood , 2006, American Journal of Nephrology.
[18] T. Libermann,et al. Urine proteomic profiling of pediatric nephrotic syndrome , 2006, Pediatric Nephrology.
[19] R J Falk,et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. , 2006, Kidney international.
[20] D. Gipson,et al. Differential risk of remission and ESRD in childhood FSGS , 2006, Pediatric Nephrology.
[21] G. Ross,et al. Early Prediction of Acute Renal Injury Using Urinary Proteomics , 2005, American Journal of Nephrology.
[22] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] A. Bagga,et al. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide , 2001, Pediatric Nephrology.
[24] A. Papagianni,et al. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] I. Ebihara,et al. The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic Syndrome , 2000, American Journal of Nephrology.
[26] R. Portman,et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. , 1999, Kidney international.
[27] D. Cattran,et al. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] M. Schwartz,et al. Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] N. Ishioka,et al. Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[30] Q. Mac,et al. Urine NGAL and IL-18 are Predictive Biomarkers for Delayed Graft Function Following Kidney Transplantation , 2006 .
[31] M. Devita,et al. Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. , 2005, Clinical nephrology.
[32] S. Korbet. Clinical picture and outcome of primary focal segmental glomerulosclerosis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.